174 related articles for article (PubMed ID: 22532599)
1. Inducible silencing of protein kinase D3 inhibits secretion of tumor-promoting factors in prostate cancer.
LaValle CR; Zhang L; Xu S; Eiseman JL; Wang QJ
Mol Cancer Ther; 2012 Jul; 11(7):1389-99. PubMed ID: 22532599
[TBL] [Abstract][Full Text] [Related]
2. PKD2 and PKD3 promote prostate cancer cell invasion by modulating NF-κB- and HDAC1-mediated expression and activation of uPA.
Zou Z; Zeng F; Xu W; Wang C; Ke Z; Wang QJ; Deng F
J Cell Sci; 2012 Oct; 125(Pt 20):4800-11. PubMed ID: 22797919
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase D3 (PKD3) contributes to prostate cancer cell growth and survival through a PKCepsilon/PKD3 pathway downstream of Akt and ERK 1/2.
Chen J; Deng F; Singh SV; Wang QJ
Cancer Res; 2008 May; 68(10):3844-53. PubMed ID: 18483269
[TBL] [Abstract][Full Text] [Related]
4. [Protein kinase D3 is involved in negative regulation of MMP-7 in prostate cancer cells].
Zou ZP; Feng L; Xu WF; Ke ZY; Wang QJ; Deng F
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Aug; 30(8):1767-70. PubMed ID: 20813660
[TBL] [Abstract][Full Text] [Related]
5. Interplay of PKD3 with SREBP1 Promotes Cell Growth via Upregulating Lipogenesis in Prostate Cancer Cells.
Li L; Hua L; Fan H; He Y; Xu W; Zhang L; Yang J; Deng F; Zeng F
J Cancer; 2019; 10(25):6395-6404. PubMed ID: 31772672
[TBL] [Abstract][Full Text] [Related]
6. SD-208, a novel protein kinase D inhibitor, blocks prostate cancer cell proliferation and tumor growth in vivo by inducing G2/M cell cycle arrest.
Tandon M; Salamoun JM; Carder EJ; Farber E; Xu S; Deng F; Tang H; Wipf P; Wang QJ
PLoS One; 2015; 10(3):e0119346. PubMed ID: 25747583
[TBL] [Abstract][Full Text] [Related]
7. New pyrazolopyrimidine inhibitors of protein kinase d as potent anticancer agents for prostate cancer cells.
Tandon M; Johnson J; Li Z; Xu S; Wipf P; Wang QJ
PLoS One; 2013; 8(9):e75601. PubMed ID: 24086585
[TBL] [Abstract][Full Text] [Related]
8. Protein Kinase D2 and D3 Promote Prostate Cancer Cell Bone Metastasis by Positively Regulating Runx2 in a MEK/ERK1/2-Dependent Manner.
Roy A; Prasad S; Chen Y; Chao Y; Liu Y; Zhao J; Wang QJ
Am J Pathol; 2023 May; 193(5):624-637. PubMed ID: 36740185
[TBL] [Abstract][Full Text] [Related]
9. Protein kinases D2 and D3 are novel growth regulators in HCC1806 triple-negative breast cancer cells.
Hao Q; McKenzie R; Gan H; Tang H
Anticancer Res; 2013 Feb; 33(2):393-9. PubMed ID: 23393329
[TBL] [Abstract][Full Text] [Related]
10. Opposing growth regulatory roles of protein kinase D isoforms in human keratinocytes.
Ryvkin V; Rashel M; Gaddapara T; Ghazizadeh S
J Biol Chem; 2015 Apr; 290(17):11199-208. PubMed ID: 25802335
[TBL] [Abstract][Full Text] [Related]
11. Effective Targeting of Estrogen Receptor-Negative Breast Cancers with the Protein Kinase D Inhibitor CRT0066101.
Borges S; Perez EA; Thompson EA; Radisky DC; Geiger XJ; Storz P
Mol Cancer Ther; 2015 Jun; 14(6):1306-16. PubMed ID: 25852060
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase Ds promote tumor angiogenesis through mast cell recruitment and expression of angiogenic factors in prostate cancer microenvironment.
Xu W; Qian J; Zeng F; Li S; Guo W; Chen L; Li G; Zhang Z; Wang QJ; Deng F
J Exp Clin Cancer Res; 2019 Mar; 38(1):114. PubMed ID: 30841931
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase d as a potential chemotherapeutic target for colorectal cancer.
Wei N; Chu E; Wipf P; Schmitz JC
Mol Cancer Ther; 2014 May; 13(5):1130-41. PubMed ID: 24634417
[TBL] [Abstract][Full Text] [Related]
14. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
Pulukuri SM; Gondi CS; Lakka SS; Jutla A; Estes N; Gujrati M; Rao JS
J Biol Chem; 2005 Oct; 280(43):36529-40. PubMed ID: 16127174
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase D3 regulates the expression of the immunosuppressive protein, PD‑L1, through STAT1/STAT3 signaling.
Cui B; Chen J; Luo M; Wang L; Chen H; Kang Y; Wang J; Zhou X; Feng Y; Zhang P
Int J Oncol; 2020 Apr; 56(4):909-920. PubMed ID: 32319563
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase D3 promotes neutrophil migration during viral infection.
Veazey JM; Wong GS; Eliseeva SI; Smyth TR; Chapman TJ; Lim K; Kim M; Georas SN
Immunol Cell Biol; 2023 Feb; 101(2):130-141. PubMed ID: 36318273
[TBL] [Abstract][Full Text] [Related]
17. [PKD3 contributes to up-regulation of prostate-specific antigen in prostate cancer cells].
Deng F; Wang CX; Xu WF; Feng L; Ke ZY; Wang QJ; Zou ZP
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Aug; 30(8):1779-82. PubMed ID: 20813663
[TBL] [Abstract][Full Text] [Related]
18. Protein Kinase D3 (PKD3) Requires Hsp90 for Stability and Promotion of Prostate Cancer Cell Migration.
Varga A; Nguyen MT; Pénzes K; Bátai B; Gyulavári P; Gurbi B; Murányi J; Csermely P; Csala M; Vántus T; Sőti C
Cells; 2023 Jan; 12(2):. PubMed ID: 36672148
[TBL] [Abstract][Full Text] [Related]
19. Phosphoglycerate mutase 1 knockdown inhibits prostate cancer cell growth, migration, and invasion.
Wen YA; Zhou BW; Lv DJ; Shu FP; Song XL; Huang B; Wang C; Zhao SC
Asian J Androl; 2018; 20(2):178-183. PubMed ID: 29271400
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase D activity is a risk biomarker in prostate cancer that drives cell invasion by a Snail/ERK dependent mechanism.
Cilleros-Rodríguez D; Toledo-Lobo MV; Martínez-Martínez D; Baquero P; Angulo JC; Chiloeches A; Iglesias T; Lasa M
Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166851. PubMed ID: 37611675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
